Lee Ann has filed 5 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 10000 shares of Coya Therapeutics, Inc. ($COYA) on January 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Coya Therapeutics, Inc. | $COYA | Lee Ann | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 20,924,456 | 9999.99% | 0.05% |
| Feb. 25, 2025 | Coya Therapeutics, Inc. | $COYA | Lee Ann | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Coya Therapeutics, Inc. | $COYA | Lee Ann | Not found | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 22, 2023 | Coya Therapeutics, Inc. | $COYA | Lee Ann | Director | P | Common Stock, par value $0.0001 per share | 1000 | $3.62 | 17,479.0000 | 0 | 6.07% | 0.00% |
| Jan. 1, 2024 | Coya Therapeutics, Inc. | $COYA | Lee Ann | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |